MENU
KHTRF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Knight Therapeutics (KHTRF) Ownership - Who owns Knight Therapeutics?
Profile
Industry
N/A
Address
3400 De Maisonneuve West
Phone
+1 514 484-4483
Employees
698
Web
https://www.gud-knight.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
390.53M
P/E Ratio
39.84
Total Cash
183.37M
Projected Growth
N/A
Total Debt
82.64M
Revenue
312.35M
Risk (Beta)
0.34
Dividend Yield
N/A
Total Cash/Share
1.71
Total Debt/Equity
N/A
Revenue/Share
2.08 USD as % of share price
Fundamentals
KHTRF
Capitalization
391M
P/E Ratio
39.84
Risk (Beta)
0.34
Dividend Yield
N/A
Total Cash
183M
Total Cash/Share
1.71
Total Debt
82.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.08%
Revenue
312M
ROE
N/A
Book Value
819M
P/B Ratio
0.64
Cash Flow
N/A
Earnings
-0.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
587M
Current Ratio
2.98
Current Revenue Per Employee
118333.81
Dividends Per Share - Security
N/A
EBITDA
44M
Float
N/A
Float - Current
N/A
Gross Income Margin
49.35
Revenue To Assets
-1.47
Shares Held By Institutions
60.5M
Shares Outstanding - Current
107M
Total Liabilities
226M
Total Volume MTD
N/A
Value
-1
Gain YTD
-5.808
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
N/A
Address
3400 De Maisonneuve West
Phone
+1 514 484-4483
Employees
698
Web
https://www.gud-knight.com